Article thumbnail

SPG20 Protein Spartin Associates with Cardiolipin via Its Plant-Related Senescence Domain and Regulates Mitochondrial Ca2+ Homeostasis

By Dinesh C. Joshi and Joanna C. Bakowska


Hereditary spastic paraplegias (HSPs) are a group of neurological disorders characterized clinically by spasticity of lower limbs and pathologically by degeneration of the corticospinal tract. Troyer syndrome is an autosomal recessive HSP caused by a frameshift mutation in the spartin (SPG20) gene. Previously, we established that this mutation results in a lack of expression of the truncated mutant spartin protein. Spartin is involved in many cellular processes and associates with several intracellular organelles, including mitochondria. Spartin contains a conserved plant-related senescence domain at its C-terminus. However, neither the function of this domain nor the roles of spartin in mitochondrial physiology are currently known. In this study, we determined that the plant-related senescence domain of spartin interacts with cardiolipin but not with two other major mitochondrial phospholipids, phosphatidylcholine and phosphatidylethanolamine. We also found that knockdown of spartin by small interfering RNA in a human neuroblastoma cell line resulted in depolarization of the mitochondrial membrane. In addition, depletion of spartin resulted in a significant decrease in both mitochondrial calcium uptake and mitochondrial membrane potential in cells treated with thapsigargin. Our results suggest that impairment of mitochondrial calcium uptake might contribute to the neurodegeneration of long corticospinal axons and the pathophysiology of Troyer syndrome

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1981). A non-disruptive technique for loading calcium buffers and indicators into cells.
  2. (2009). A role for ubiquitin ligases and Spartin/SPG20 in lipid droplet turnover.
  3. (2004). Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury.
  4. (2007). Coupling cystic fibrosis to endoplasmic reticulum stress:
  5. (1995). Decoding of cytosolic calcium oscillations in the mitochondria.
  6. (2011). Determination of mitochondrial membrane potential and reactive oxygen species in live rat cortical neurons.
  7. (2002). Early mitochondrial calcium defects in Huntington’s disease are a direct effect of polyglutamines.
  8. (2009). Endogenous spartin (SPG20) is recruited to endosomes and lipid droplets and interacts with the ubiquitin E3 ligases AIP4 and AIP5.
  9. (2006). Endogenous spartin, mutated in hereditary spastic paraplegia, has a complex subcellular localization suggesting diverse roles in neurons.
  10. (2002). Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60.
  11. (2009). Identification of novel spartininteractors shows spartin is a multifunctional protein.
  12. (2000). Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities.
  13. (2002). Is the transportation highway the right road for hereditary spastic paraplegia?
  14. (2008). Lack of spartin protein in Troyer syndrome: a loss-of-function disease mechanism?
  15. (2002). Lipid droplet binding and oligomerization properties of the Parkinson’s disease protein alpha-synuclein.
  16. (2007). Localization of alphasynuclein to mitochondria within midbrain of mice.
  17. (2003). Loss of mAAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia.
  18. (2006). Low stability of Huntington muscle mitochondria against Ca2+ in R6/2 mice.
  19. (2002). Measurements of ATP in mammalian cells.
  20. (1999). Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1.
  21. (2000). Mitochondria and calcium: from cell signalling to cell death.
  22. (2000). Mitochondria and neuronal survival.
  23. (2004). Mitochondria in health and disease: perspectives on a new mitochondrial biology.
  24. (2008). Mitochondria: the hub of cellular Ca2+ signaling.
  25. (2005). Mitochondrial dysfunction and its role in motor neuron degeneration in ALS.
  26. (2002). Mitochondrial Hsp60, resistance to oxidative stress, and the labile iron pool are closely connected in Saccharomyces cerevisiae.
  27. (2008). Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells.
  28. (2005). Mitochondrial nitric oxide mediates decreased vulnerability of hippocampal neurons from immature animals to NMDA.
  29. (2008). Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification.
  30. (2000). Mitochondrial translocation of protein kinase C delta in phorbol ester-induced cytochrome c release and apoptosis.
  31. (2001). Molecular basis of inherited spastic paraplegias.
  32. (2006). Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences.
  33. (2008). Nitric oxide-mediated modulation of synaptic activity by astrocytic P2Y receptors.
  34. (2002). Oleic acid-induced PKC isozyme translocation in RAW 264.7 macrophages.
  35. (2000). Oxidative phosphorylation in cardiolipinlacking yeast mitochondria.
  36. (1997). Phospholipid composition of highly purified mitochondrial outer membranes of rat liver and Neurospora crassa. Is cardiolipin present in the mitochondrial outer membrane?
  37. (2010). PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/ SQSTM1.
  38. (1999). Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis.
  39. (2007). Role of glycolytically generated ATP for CaMKII-mediated regulation of intracellular Ca2+ signaling in bovine vascular endothelial cells.
  40. (2005). S3-12, Adipophilin, and TIP47 package lipid in adipocytes.
  41. (1989). Simultaneous imaging of cell and mitochondrial membrane potentials.
  42. (2010). Spartin activates atrophin-1-interacting protein 4 (AIP4) E3 ubiquitin ligase and promotes ubiquitination of adipophilin on lipid droplets.
  43. (1998). Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease.
  44. (2002). SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia.
  45. (2006). The hereditary spastic paraplegia protein spartin localises to mitochondria.
  46. (2002). The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space.
  47. (2003). The identification of a conserved domain in both spartin and spastin, mutated in hereditary spastic paraplegia.
  48. (2005). The Troyer syndrome (SPG20) protein spartin interacts with Eps15.
  49. (1967). The Troyer syndrome. A recessive form of spastic paraplegia with distal muscle wasting.
  50. (2006). Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.
  51. (2007). Troyer syndrome protein spartin is mono-ubiquitinated and functions in EGF receptor trafficking.
  52. (1995). Use of thapsigargin to study Ca2+ homeostasis in cardiac cells.